Skip to main content
. 2024 Mar 6;14(1):38. doi: 10.1038/s41408-024-01024-8

Fig. 3. The PBM scores are associated with the intrinsic molecular characteristics of MM.

Fig. 3

A Patients with cytogenetic abnormalities had higher PBM scores than those without in the CoMMpass, MAQC-II, and UAMS-I datasets. B Among the ten cytogenetic abnormalities, the difference in PBM scores between patients with this cytogenetic abnormality and those without in the CoMMpass dataset. C PBM scores of patients that were classified into the UAMS molecular subtype groups (CD1, CD2, HY, LB, MF, MS, and PR) in the UAMS-I dataset.